Island Pharmaceuticals Limited to list on the ASX today following oversubscribed A$7.5m IPO

MELBOURNE, Australia, April 13, 2021 /PRNewswire/ -- Australian antiviral drug development company, Island Pharmaceuticals (Island) is set to list on the Australian Securities Exchange (ASX) today after raising A$7.5 million through its Initial Public Offer (IPO) which was significantly oversubscribed.

Island shares are due to begin trading on the...

Read more: Island Pharmaceuticals Limited to list on the ASX today following oversubscribed A$7.5m IPO

More Articles …

  1. Digital Cooperation Organization welcomes Nigeria and Oman as founding members, and launches several initiatives
  2. Appian appoints Richard Johnson as Global Head of Investor Relations
  3. EcoVadis Platinum Sustainability Awarded to Down Under Enterprises
  4. Riva Technology and Entertainment signs brand licensing deal with Global toy giant MGA Entertainment
  5. TTC Becomes First Approved Supplier of Accessibility Services for Both Australian New Zealand Digital Marketplaces
  6. IEC Telecom: Digital revolution brings new ways of serving remote areas
  7. Gazprom Football for Friendship 2021: Young Participants from 211 countries and regions to set new GUINNESS WORLD RECORDS™ title
  8. Bionomics Successfully Completes A$22.9 million Equity Raise
  9. Panduit(TM) Australia releases NEW Contractor Grade Epson hand-held printers
  10. Control Bionics (ASX:CBL) Partners with Numotion as Northeastern U.S. Reseller of Assistive Technology Solutions